+43 2635 21012 500 Schwarzottstraße 2a | 2620 Neunkirchen beratung@permedio.at

Referenzen

Hier finden Sie einige Referenzen zum MediCheck.

  1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:1200-5.
  2. Gurwitz JH, Field TS, Avorn J, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000;109:87-94.
  3. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1997;277:301-6.
  4. Davey AL, Britland A, Naylor RJ. Decreasing paediatric prescribing errors in a district general hospital. Qual Saf Health Care 2008;17:146-9.
  5. Jha AK, Kuperman GJ, Rittenberg E, Teich JM, Bates DW. Identifying hospital admissions due to adverse drug events using a computer-based monitor. Pharmacoepidemiol Drug Saf 2001;10:113-9.
  6. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995;274:29-34.
  7. Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. Adverse drug events occurring following hospital discharge. J Gen Intern Med 2005;20:317-23.
  8. Beijer HJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002;24:46-54.
  9. Goldberg RM1, Mabee J, Chan L, Wong S., Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population., Am J Emerg Med. 1996 Sep;14(5):447-50.
  10. M. Whirl-Carrillo, E. M. McDonagh, J. M. Hebert, L. Gong, K. Sangkuhl, C. F. Thorn, R. B. Altman and T. E. Klein. „Pharmacogenomics Knowledge for Personalized Medicine“ Clinical Pharmacology & Therapeutics (2012) 92(4): 414-417.
  11. CH van der Wouden, A Cambon-Thomsen, E Cecchin, KC Cheung, CL Davila-Fajardo5, VH Deneer, V Dolzan, M Ingelman-Sundberg, S J€onsson, MO Karlsson, M Kriek, C Mitropoulou, GP Patrinos, M Pirmohamed, M Samwald, E Schaeffeler, M Schwab, D Steinberger, J Stingl, G Sunder-Plassmann, G Toffoli, RM Turner, MH van Rhenen, JJ Swen, and H-J Guchelaar on behalf of the Ubiquitous Pharmacogenomics Consortium. Clinical Pharmacology & Therapeutics (2017) 101(3): 341-358